Synergy CHC Corp. Common Stock

Day range

$0.09 – $0.16

Open

$0.14

Prev close

$0.09

Volume

70.12M

Market cap

—

Shares out

—

• Voluntary bankruptcySep 16, 2026

  Synergy CHC Corp. (the "Company") and certain of its subsidiaries filed voluntary petitions for relief under chapter 11 of Title 11 of the United States Bankruptcy Code ... on September 4, 2026 (the "Bankruptcy Filing").

• Director departureSep 8, 2026

  Effective September 4, 2026, immediately following the filing of the chapter 11 petition described under Item 1.03 above, Alfred Baumeler, Nitin Kaushal, J. Paul SoRelle and Teresa Thompson resigned as members of the Company's Board of Directors.

• Debt accelerationAug 26, 2026

  On August 25, 2026, Synergy CHC Corp. received a Notice of Acceleration from ACP Agency, LLC, as administrative agent under the Company's Term Loan Credit Agreement. Pursuant to the Acceleration Notice, ACP notified the Company that all commitments under the Credit Agreement have been terminated and that all obligations outstanding under the Credit Agreement and the related loan documents have been accelerated and declared immediately due and payable.

• Listing deficiency noticeAug 21, 2026

  On August 20, 2026, Synergy CHC Corp. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026 (the "Form 10-Q"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.

• Payment defaultAug 11, 2026

  ACP asserted that an Event of Default occurred under the Credit Agreement as a result of the Company's failure to make the interest payment due on August 3, 2026 following expiration of the applicable cure period on August 6, 2026.

Days to cover

1.0

Short interest

2.23M

Avg volume

47.7M

As of Sep 15, 2026 · reported to FINRA twice monthly.

• Synergy CHC Shares Surge Nearly 100% In After-Hours Trading: What's Going On?
  neutralBenzinga· Apr 14, 2026
• Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options
  neutralGlobeNewswire Inc.· Dec 26, 2025
• Alkane Resources Limited: Appointment of Non-Executive Director
  neutralGlobeNewswire Inc.· Nov 24, 2025
• Synergy CHC Corp. Announces Pricing of $4.375 Million Public Offering
  positiveGlobeNewswire Inc.· Aug 25, 2025
• Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
  positiveGlobeNewswire Inc.· Aug 14, 2025